Lindbrook Capital, LLC Edwards Lifesciences Corp Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Lindbrook Capital, LLC holds 3,718 shares of EW stock, worth $275,578. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,718

Previous 4,096 9.23%

Holding current value

$275,578

Previous $378,000 35.19%

% of portfolio

0.02%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$59.7 - $93.78 $22,566 - $35,448	-378 Reduced 9.23%	3,718 $245,000
Q2 2024 Jul 31, 2024	BUY	$84.3 - $94.31 $14,162 - $15,844	168 Added 4.28%	4,096 $378,000
Q1 2024 Apr 25, 2024	BUY	$72.54 - $95.56 $7,108 - $9,364	98 Added 2.56%	3,928 $375,000
Q4 2023 Jan 31, 2024	BUY	$61.71 - $77.76 $15,118 - $19,051	245 Added 6.83%	3,830 $292,000
Q3 2023 Oct 25, 2023	SELL	$69.28 - $93.38 $35,402 - $47,717	-511 Reduced 12.48%	3,585 $248,000
Q2 2023 Jul 28, 2023	BUY	$81.41 - $94.33 $3,989 - $4,622	49 Added 1.21%	4,096 $386,000
Q1 2023 Apr 26, 2023	BUY	$74.26 - $84.51 $55,100 - $62,706	742 Added 22.45%	4,047 $334,000
Q4 2022 Jan 24, 2023	SELL	$68.3 - $87.44 $22,743 - $29,117	-333 Reduced 9.15%	3,305 $0
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $7,989 - $10,407	-97 Reduced 2.6%	3,638 $301,000
Q2 2022 Aug 01, 2022	BUY	$86.5 - $128.27 $259,240 - $384,425	2,997 Added 406.1%	3,735 $355,000
Q1 2022 Apr 21, 2022	BUY	$101.96 - $128.34 $9,584 - $12,063	94 Added 14.6%	738 $87,000
Q4 2021 Jan 18, 2022	SELL	$106.37 - $130.68 $1,701 - $2,090	-16 Reduced 2.42%	644 $83,000
Q3 2021 Nov 05, 2021	SELL	$102.91 - $122.75 $205 - $245	-2 Reduced 0.3%	660 $75,000
Q2 2021 Jul 27, 2021	BUY	$83.84 - $104.76 $4,443 - $5,552	53 Added 8.7%	662 $69,000
Q1 2021 Apr 28, 2021	BUY	$78.68 - $90.67 $6,766 - $7,797	86 Added 16.44%	609 $51,000
Q4 2020 Jan 27, 2021	BUY	$71.69 - $91.23 $358 - $456	5 Added 0.97%	523 $48,000
Q3 2020 Nov 03, 2020	SELL	$67.19 - $87.44 $671 - $874	-10 Reduced 1.89%	518 $41,000
Q2 2020 Jul 27, 2020	BUY	$57.54 - $76.95 $21,519 - $28,779	374 Added 242.86%	528 $36,000
Q1 2020 Apr 22, 2020	SELL	$52.41 - $81.0 $7,442 - $11,502	-142 Reduced 47.97%	154 $29,000
Q3 2019 Oct 31, 2019	BUY	$61.55 - $75.43 $1,600 - $1,961	26 Added 9.63%	296 $65,000
Q1 2019 Apr 23, 2019	BUY	$47.89 - $64.05 $4,310 - $5,764	90 Added 50.0%	270 $51,000
Q4 2018 Feb 07, 2019	BUY	$46.41 - $56.94 $8,353 - $10,249	180 New	180 $27,000

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Edwards Lifesciences Corp Transaction History